Conformal Medical

Conformal Medical is a developer of a novel left atrial appendage occlusion (LAAO) system aimed at reducing stroke risk in AFib patients without the long-term need for anticoagulants. Its CLAAS System is designed to be a same-day, single-operator procedure, potentially improving ease of use and accessibility. The company was acquired by medical device giant W. L. Gore & Associates in early 2026, providing significant resources and commercial expertise to advance the technology through clinical development and future commercialization. The acquisition represents a strategic expansion of Gore's cardiac portfolio into a high-growth adjacency.

Proprietary device platform for left atrial appendage occlusion (LAAO), designed to enable a same-day, single-operator procedure. The CLAAS AcuFORM System is engineered to conform to patient anatomy for a secure seal.

The LAAO market is competitive, dominated by major players like Abbott (Amplatzer Amulet) and Boston Scientific (WATCHMAN FLX). Conformal's CLAAS System aims to compete on procedural simplicity and ease of use, targeting broader physician adoption. Its integration into Gore provides a strong commercial and support counterpart to these competitors.